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in the transparent dressing group: longer dressing change
interval, longer duration of catheter use, and less use of
topical antibiotics. The authors discuss but dismiss these
covariates. Also, they combine studies with different brands
of transparent dressing—brands are not interchangeable.4
A typographical error in Table 3 inadvertently exchanged
proportions of phlebitis in the Nicola and DeChairo study:
78/255 (30.6%) applies to gauze and not transparent; 58/270
(21.5%) applies to transparent and not gauze dressings (the
relative risk [RR] is correct.) This difference is statistically
significant in favor of transparent dressing. Maki and Will5
did not find skin colonization rates significantly greater using
transparent as opposed to gauze dressings when both were
changed every 2 days. Arterial catheter data from Maki and
Will6 should have been excluded; some transparent dressings
are contraindicated for arterial use. Abstracts are subject to
the same biases as published articles, and so do not "avoid
publication bias."
Significant differences in catheter-tip infection do not im¬
ply correspondingly significant differences in clinical infec¬
tion. There were no statistically significant increases in any
clinical infection due to transparent dressings. Finally, co¬
variates not considered in the authors' statistical analyses
could more than make up for observed differences in dressing
type.
Donald A. Berry, PhD
Duke University
Durham, NC
Since 1980, Dr Berry has been a paid consultant to the 3M Corporation,
manufacturer of Tegaderm® transparent dressing.
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In Reply.\p=m-\Whencomparing the infection risks of transpar-
ent vs gauze dressings used on central venous catheters, the
RRs were 1.78 for catheter-tip infection, 1.63 for bacteremia,
and 1.69 for catheter sepsis. These RRs represent the best
assessment of the overall risk associated with the use of
transparent dressings. (For catheter-tip infection, P<.001;
for catheter sepsis, P=.06.) In our discussion we used the
word "trend" in discussing this level of significance. The
choice of .05 as the level of "statistical significance" is arbi-
trary, and given the RRs demonstrated in the meta-analysis,
further studies are warranted before accepting transparent
dressings as safe.
Dr Berry notes that a recent review by Maki1 states that
quantitative cultures of catheter tips have a "15 to 40 percent
association with concomitant bacteremias." We disagree with
Berry's conclusions regarding the significance of a positive
catheter-tip culture. Dr Maki notes that "most catheter-re-
lated septicemias derive from local infection of the transcu-
taneous cannula tract." We did not state that catheter-tip
infection and catheter sepsis need occur simultaneously, but
rather that the former is a precursor to the latter. We also
recognize that not all catheter-tip infections proceed to sep-
sis. The two references (ie, Maki1 and Nahass and Weinstein2)
cited by Berry describe the predictive value of catheter-tip
infection for concurrent sepsis, which is an entirely different
issue.
Many of the studies we cited had differences as noted
by Berry, but these differences did not bias our results.
As we noted, the differences in duration of catheter use
were not significant. There was somewhat greater use of
antibacterial ointments in the gauze groups, but this addi¬
tional use was small compared with the large number of
catheters studied. Transparent dressings were changed
less frequently than gauze dressings. Transparent dress¬
ings have been promoted as advantageous for two reasons:
the need for less frequent changes and the ability to visu¬
alize the insertion site to allow assessment of local infec¬
tion.
For these reasons, all seven studies ofperipheral catheters
used longer dressing intervals for transparent dressings. As
such, our analysis reflected differences in the way transpar¬
ent and gauze dressings are currently used. Changing trans¬
parent dressing as frequently as is currently done with gauze
dressing would result in higher dressing cost. Further, use of
antibacterial ointment under a transparent dressing obscures
the insertion site.
We appreciate Berry's notes of a typographical error in
Table 3. While it is true that including abstracts does not
solve the problem of publication bias, including these sources
may serve to ameliorate its effects. Another approach to the
issue of publication bias involves the "file-drawer problem"
(ie, estimating the number of negative studies required to
eliminate the observed statistical significance). Using the
method of combining  scores,3 one would need in excess of
64 central venous catheter studies and 30 peripheral venous
studies to negate the observed statistical significance for the
catheter-tip infection outcome. This calculation can be veri¬
fied using data from Tables 2 and 4.
Lastly, we feel that Berry's comments unfairly argue
for placing the burden of proving that new technologies
such as transparent dressings are safe on the unbiased
scientific community. Rather, companies that introduce
new technologies should provide studies of adequate
power to ensure that these technologies are least as safe
as current methods.
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T-Lymphocyte Subsets in Intravenous Drug Users
With HIV-1 Infection
To the Editor.\p=m-\Recently,Margolick et al1 reported on chang-
es in CD4 and CD8 T-lymphocyte subsets in intravenous drug
users (IVDUs). In their words, "The principal finding was the
slow rate of decline in CD4 lymphocyte counts in HIV-1
[human immunodeficiency virus type 1] seropositive IVDUs
over a 2.5-year period of observation." (Actual observation
period was 18 months.) The authors assert that this finding
contradicts "the common perception that HIV-1 infection in
IVDUs leads to rapid decline in CD4 lymphocytes." Howev-
